Home » EMEA: DES Coronary Stentmakers Must Show Drug-Device Compatibility
EMEA: DES Coronary Stentmakers Must Show Drug-Device Compatibility
July 8, 2008
Manufacturers of drug-eluting coronary stents (DESs) must provide the results of biocompatibility tests of the bare stent platform conducted to support the start of clinical trials, according to a final guidance by the European Medicines Agency’s (EMEA) Committee on Human Medicinal Products (CHMP).
To View This Article:
Subscribe To International Medical Device Regulatory Monitor